The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The Propofol API is an intravenous, short acting anesthetic with rapid onset of action used in the induction and maintenance of anesthesia.
The global Propofol market was valued at US$ 18 million in 2023 and is anticipated to reach US$ 22 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Bachem is the world's largest manufacturers of Propofol, with a market share of nearly 50%, other major manufacturers include Curia and SI Group. Europe dominates the global propofol market with market share 60% in production, followed by China and India. In terms of product types, propofol with purity below 99.5% occupied more than 99% of the share, and the rest is propofol with purity over 99.5%. In terms of product application, propofol injection emulsion occupies for a share of 65%, and propofol mct/lct injection occupies for a share of 35%.
This report aims to provide a comprehensive presentation of the global market for Propofol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Propofol.
Report Scope
The Propofol market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Propofol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Propofol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Segment by Type
Purity above 99.5%
Purity below 99.5%
Segment by Application
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Propofol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Propofol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The Propofol API is an intravenous, short acting anesthetic with rapid onset of action used in the induction and maintenance of anesthesia.
The global Propofol market was valued at US$ 18 million in 2023 and is anticipated to reach US$ 22 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.
Bachem is the world's largest manufacturers of Propofol, with a market share of nearly 50%, other major manufacturers include Curia and SI Group. Europe dominates the global propofol market with market share 60% in production, followed by China and India. In terms of product types, propofol with purity below 99.5% occupied more than 99% of the share, and the rest is propofol with purity over 99.5%. In terms of product application, propofol injection emulsion occupies for a share of 65%, and propofol mct/lct injection occupies for a share of 35%.
This report aims to provide a comprehensive presentation of the global market for Propofol, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Propofol.
Report Scope
The Propofol market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Propofol market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Propofol manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
Curia
SI Group
Neuland Laboratories
Harman Finochem
Midas Pharma
Guangdong Jiabo Pharmaceutical
Sichuan Biokin Pharmaceutical
Xi’an Libang Pharmaceutical
Beijing Sciecure Pharmaceutical
Jiangsu Nhwa Pharmaceutical
Segment by Type
Purity above 99.5%
Purity below 99.5%
Segment by Application
Propofol Injectable Emulsion
Propofol MCT/LCT Injectable Emulsion
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Propofol manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Propofol in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Propofol Market Overview
1.1 Product Overview and Scope of Propofol
1.2 Propofol Segment by Type
1.2.1 Global Propofol Market Value Comparison by Type (2024-2030)
1.2.2 Purity above 99.5%
1.2.3 Purity below 99.5%
1.3 Propofol Segment by Application
1.3.1 Global Propofol Market Value by Application: (2024-2030)
1.3.2 Propofol Injectable Emulsion
1.3.3 Propofol MCT/LCT Injectable Emulsion
1.4 Global Propofol Market Size Estimates and Forecasts
1.4.1 Global Propofol Revenue 2019-2030
1.4.2 Global Propofol Sales 2019-2030
1.4.3 Global Propofol Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Propofol Market Competition by Manufacturers
2.1 Global Propofol Sales Market Share by Manufacturers (2019-2024)
2.2 Global Propofol Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Propofol Average Price by Manufacturers (2019-2024)
2.4 Global Propofol Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Propofol, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Propofol, Product Type & Application
2.7 Propofol Market Competitive Situation and Trends
2.7.1 Propofol Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Propofol Players Market Share by Revenue
2.7.3 Global Propofol Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Propofol Retrospective Market Scenario by Region
3.1 Global Propofol Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Propofol Global Propofol Sales by Region: 2019-2030
3.2.1 Global Propofol Sales by Region: 2019-2024
3.2.2 Global Propofol Sales by Region: 2025-2030
3.3 Global Propofol Global Propofol Revenue by Region: 2019-2030
3.3.1 Global Propofol Revenue by Region: 2019-2024
3.3.2 Global Propofol Revenue by Region: 2025-2030
3.4 North America Propofol Market Facts & Figures by Country
3.4.1 North America Propofol Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Propofol Sales by Country (2019-2030)
3.4.3 North America Propofol Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Propofol Market Facts & Figures by Country
3.5.1 Europe Propofol Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Propofol Sales by Country (2019-2030)
3.5.3 Europe Propofol Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Propofol Market Facts & Figures by Country
3.6.1 Asia Pacific Propofol Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Propofol Sales by Country (2019-2030)
3.6.3 Asia Pacific Propofol Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Propofol Market Facts & Figures by Country
3.7.1 Latin America Propofol Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Propofol Sales by Country (2019-2030)
3.7.3 Latin America Propofol Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Propofol Market Facts & Figures by Country
3.8.1 Middle East and Africa Propofol Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Propofol Sales by Country (2019-2030)
3.8.3 Middle East and Africa Propofol Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Propofol Sales by Type (2019-2030)
4.1.1 Global Propofol Sales by Type (2019-2024)
4.1.2 Global Propofol Sales by Type (2025-2030)
4.1.3 Global Propofol Sales Market Share by Type (2019-2030)
4.2 Global Propofol Revenue by Type (2019-2030)
4.2.1 Global Propofol Revenue by Type (2019-2024)
4.2.2 Global Propofol Revenue by Type (2025-2030)
4.2.3 Global Propofol Revenue Market Share by Type (2019-2030)
4.3 Global Propofol Price by Type (2019-2030)
5 Segment by Application
5.1 Global Propofol Sales by Application (2019-2030)
5.1.1 Global Propofol Sales by Application (2019-2024)
5.1.2 Global Propofol Sales by Application (2025-2030)
5.1.3 Global Propofol Sales Market Share by Application (2019-2030)
5.2 Global Propofol Revenue by Application (2019-2030)
5.2.1 Global Propofol Revenue by Application (2019-2024)
5.2.2 Global Propofol Revenue by Application (2025-2030)
5.2.3 Global Propofol Revenue Market Share by Application (2019-2030)
5.3 Global Propofol Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bachem
6.1.1 Bachem Corporation Information
6.1.2 Bachem Description and Business Overview
6.1.3 Bachem Propofol Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bachem Propofol Product Portfolio
6.1.5 Bachem Recent Developments/Updates
6.2 Curia
6.2.1 Curia Corporation Information
6.2.2 Curia Description and Business Overview
6.2.3 Curia Propofol Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Curia Propofol Product Portfolio
6.2.5 Curia Recent Developments/Updates
6.3 SI Group
6.3.1 SI Group Corporation Information
6.3.2 SI Group Description and Business Overview
6.3.3 SI Group Propofol Sales, Revenue and Gross Margin (2019-2024)
6.3.4 SI Group Propofol Product Portfolio
6.3.5 SI Group Recent Developments/Updates
6.4 Neuland Laboratories
6.4.1 Neuland Laboratories Corporation Information
6.4.2 Neuland Laboratories Description and Business Overview
6.4.3 Neuland Laboratories Propofol Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Neuland Laboratories Propofol Product Portfolio
6.4.5 Neuland Laboratories Recent Developments/Updates
6.5 Harman Finochem
6.5.1 Harman Finochem Corporation Information
6.5.2 Harman Finochem Description and Business Overview
6.5.3 Harman Finochem Propofol Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Harman Finochem Propofol Product Portfolio
6.5.5 Harman Finochem Recent Developments/Updates
6.6 Midas Pharma
6.6.1 Midas Pharma Corporation Information
6.6.2 Midas Pharma Description and Business Overview
6.6.3 Midas Pharma Propofol Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Midas Pharma Propofol Product Portfolio
6.6.5 Midas Pharma Recent Developments/Updates
6.7 Guangdong Jiabo Pharmaceutical
6.6.1 Guangdong Jiabo Pharmaceutical Corporation Information
6.6.2 Guangdong Jiabo Pharmaceutical Description and Business Overview
6.6.3 Guangdong Jiabo Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Guangdong Jiabo Pharmaceutical Propofol Product Portfolio
6.7.5 Guangdong Jiabo Pharmaceutical Recent Developments/Updates
6.8 Sichuan Biokin Pharmaceutical
6.8.1 Sichuan Biokin Pharmaceutical Corporation Information
6.8.2 Sichuan Biokin Pharmaceutical Description and Business Overview
6.8.3 Sichuan Biokin Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sichuan Biokin Pharmaceutical Propofol Product Portfolio
6.8.5 Sichuan Biokin Pharmaceutical Recent Developments/Updates
6.9 Xi’an Libang Pharmaceutical
6.9.1 Xi’an Libang Pharmaceutical Corporation Information
6.9.2 Xi’an Libang Pharmaceutical Description and Business Overview
6.9.3 Xi’an Libang Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Xi’an Libang Pharmaceutical Propofol Product Portfolio
6.9.5 Xi’an Libang Pharmaceutical Recent Developments/Updates
6.10 Beijing Sciecure Pharmaceutical
6.10.1 Beijing Sciecure Pharmaceutical Corporation Information
6.10.2 Beijing Sciecure Pharmaceutical Description and Business Overview
6.10.3 Beijing Sciecure Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Beijing Sciecure Pharmaceutical Propofol Product Portfolio
6.10.5 Beijing Sciecure Pharmaceutical Recent Developments/Updates
6.11 Jiangsu Nhwa Pharmaceutical
6.11.1 Jiangsu Nhwa Pharmaceutical Corporation Information
6.11.2 Jiangsu Nhwa Pharmaceutical Propofol Description and Business Overview
6.11.3 Jiangsu Nhwa Pharmaceutical Propofol Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Jiangsu Nhwa Pharmaceutical Propofol Product Portfolio
6.11.5 Jiangsu Nhwa Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Propofol Industry Chain Analysis
7.2 Propofol Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Propofol Production Mode & Process
7.4 Propofol Sales and Marketing
7.4.1 Propofol Sales Channels
7.4.2 Propofol Distributors
7.5 Propofol Customers
8 Propofol Market Dynamics
8.1 Propofol Industry Trends
8.2 Propofol Market Drivers
8.3 Propofol Market Challenges
8.4 Propofol Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
